Novel Therapeutics

(40:46)

Overview of Next Generation Novel Therapeutics in Myelofibrosis - 2024 Blood Cancer OncTalk

(2:45)

Novel therapeutics in essential thrombocythemia

(35)

Updates: Novel Therapeutics - E Hollander, MD

(1:16:35)

Gender and CKD Progression: Can Novel Therapeutics make a Difference? | Karolina Kublickiene, MD

(36:1econd)

Developing Novel Therapeutics in Autism Spectrum Disorder: Trials and Tribulations

(47:15)

Novel Therapeutics for Neurobehavioral Aspects of ASD – S Lipton, MD PhD, Scripps @Synchrony2020

(33:51)

Webinar: Viral RNA Modifications and Implications for Novel Therapeutics

(51:46)

Cancer as a metabolic disease: implications for novel therapeutics

(25:25)

Novel Therapeutics in Ovarian Cancer: What to Watch

(27:39)

Grand Rounds: Novel Therapeutics in Depression: Ketamine, Esketamine, and Psychedelics

(57:53)

Keynote - Novel Therapeutics in Cancer (Jose Baselga)

(29:34)

Novel Therapeutics for Fibrotic Disease: Has Their Time Finally Arrived?

(1:1:53)

A Very Long and Winding Road: Developing Novel Therapeutics for Metastatic Tumors | Oncoscience

(1:2)

Novel Therapeutics in Relapsed Setting for Diffuse Large B-Cell Lymphoma - 2024 Blood Cancer OncTalk

(7:42)

Bacteria as Sources for Novel Therapeutics

(2:57)

Fibrosis: Basic Mechanisms \u0026 Novel Therapeutics - The Liver Meeting 2013

(4:15)

Oxford Cancer Theme Video - Novel Therapeutics

(2:6)

Novel therapeutics to repair damage in multiple sclerosis

(1:31)

'Miracle poison' for novel therapeutics

(8:14)